In 2018, we’ve tracked AI edging its way into many corners of health care, primarily in diagnostics but also in patient monitoring, selecting dosing regimens, and drug development.
Well, here’s a new one for you—an AI program that loves crappy health care software.
When Sean Lane, a former NSA operative who served five tours of duty in Afghanistan and Iraq, first entered into the health care-AI arena, he was overwhelmed with data silos, systems that don’t speak to each other, and many, many portals and screens.
“I was not going to create another screen,” Lane told a packed room on Monday at ApplySci’s annual health technology conference at the MIT Media Lab in Cambridge, Mass.
Instead, Lane and a team taught an AI system to use software that already exists in health care just like a human would use it. They named it Olive.
“Olive loves all that crappy software that health care already has,” said Lane. “Olive can look at any software program, any application for the first time she’s ever seen it, and understand how to use it.”
For example, Olive navigates electronic medical records, logs into hospital portals, creates reports, files insurance claims, and more.
Olive does so thanks to three key traits. First, using computer vision and Robotic Process Automation, or RPA, the program can interact with any software interface just as a human would, opening browsers and typing. Second, machine learning enables Olive to make decisions the way human health care workers do. The team trained Olive with historical data on how health care workers perform digital tasks, such as how to file an insurance eligibility check for a patient seeking to undergo a procedure.
Finally, Olive relies on a unique skill that Lane developed based on his work at the NSA identifying criminals across disparate government sources—the ability to match identities across databases. Just as NSA software can determine if a terrorist in the CIA database is the same as in the Homeland Security database, so Olive matches a patient across disparate databases and software, such as multiple electronic health care record programs.
Photo: Megan Scudellari
Lane formed a health care tech company in 2012 and began building the Olive software in 2017. Today, Olive—both the company and the software name—is 120 employees strong in Columbus, Ohio. The software became commercially available 18 months ago and is currently being used in 195 hospitals and health care companies, Lane told IEEE Spectrum.
So far, those users have primarily put Olive to work automating insurance eligibility checks and claim status denials, said Lane. In the future, he hopes users will also adopt the tech to handle medical records and identify cohorts for clinical trials.
Like Steve Jobs and his fruit-named company, Lane has grand visions for his technology. Once Olive bots are widely adopted, Lane surmises, they could be used to communicate among health care organizations and to be queried like a Google for health care. This “Internet of Health Care,” as Lane calls it, would connect previously siloed health care systems into a convenient, searchable online community enabled by AI.
But for that to happen, Olive bots would need to be widespread among health care computers. Like the early days of Arpanet, “we need everyone to buy a modem, and that modem is Olive,” Lane told Spectrum.
Another challenge to an Internet of Health Care is privacy. Rules for sharing patient data can be built into each bot at a hospital or health care center so that they share data only for specific business or medical reasons. “It’s very difficult, but it is doable,” says Lane. Similar systems are in place in intelligence communities, he adds.
Megan is an award-winning freelance journalist based in Boston, Massachusetts, specializing in the life sciences and biotechnology. She was previously a health columnist for the Boston Globe and has contributed to Newsweek, Scientific American, and Nature, among others. She is the co-author of a college biology textbook, “Biology Now,” published by W.W. Norton. Megan received an M.S. from the Graduate Program in Science Writing at the Massachusetts Institute of Technology, a B.A. at Boston College, and worked as an educator at the Museum of Science, Boston.